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Abstract: Glycosaminoglycans (GAG), are extra-
cellular matrix macromolecules that affect the
phagocytic properties of macrophages. In order to
assess whether the interaction between macro-
phages and Candida albicans (iCa) provokes changes
in the phenotype, we analyzed the GAG profiles in
two macrophage lines, ANA-1 (from murine bone-
marrow) and BV-2 (from murine brain). We also
investigated GAG modulation by interleukin-1a
(IL-1a) and interleukin-6 (IL-6). During iCa treat-
ment and even after the addition of ILs, ANA-1
accumulated less total GAG compared to controls.
IL-1 treatment, combined with iCa exposure, in-
duced a decrease in heparan sulfate and chondroi-
tin sulfate chains, and an increase in the hyaluronic
acid percentage. IL-6 treatment, with or without
iCa, decreased the hyaluronic acid/sulfated GAG
ratio. The GAG pattern in BV-2 appears to be
different to ANA-1 and iCa exposure does not
induce any difference in total GAG. The inhibitory
effect induced by ILs on GAG synthesis is less than
that observed in ANA-1 and the GAG elution profile
is modulated to a lesser extent by treatment with
ILs and/or iCa compared to the ANA-1. We suggest
that the observed changes in the expression of the
individual GAG classes may be responsible for the
macrophage functional heterogeneity. J. Leukoc.
Biol. 64: 650–656; 1998.
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INTRODUCTION
Macrophages belong to the mononuclear phagocyte system
involved in many host defense functions such as the uptake and
elimination of parasites, the processing and presentation of
antigens to the immune system, and the destruction of trans-
formed cells. Although deriving from a relatively homogenous
population of precursor cells, their functional heterogeneity is
determined on the basis of their capacity to secrete growth
factors, depending on their developmental stage, and in particu-
lar due to a specific stimulus dictated by the microenvironment
to which the macrophages are exposed. These stimuli induce
transmembrane and intracellular signaling events leading to
diversity in gene expression and in macrophage phenotype
[1, 2].
During inflammatory processes, the monocytes leave the
circulation and migrate to the extravascular area where many
cellular types (fibroblasts, neutrophils, lymphocytes, etc.) pro-
duce extracellular matrix (ECM) proteins. ECM is principally
composed of proteoglycans (PG), which include sulfated and
non-sulfated GAG such as hyaluronic acid (HA). Sulfated GAG
such as chondroitin sulfate (CS), dermatan sulfate (DS), and
heparan sulfate (HS) are in turn covalently attached to a core
protein. The ECM not only serves a mechanical role in
supporting and maintaining tissue structures, but also modu-
lates a multitude of cell functions such as development and
proliferation [3], thus playing a critical role in the migration of
macrophages to the target tissues or inflammatory foci. In fact,
ECM components have been shown to interact with the cell
surface molecules of leukocytes thus facilitating cell migration
or proliferation [4–7]. Laminin, an ECM molecule present at
sites of immune and inflammatory responses, enhances comple-
ment and Fc-mediated phagocytosis in cultured human macro-
phages [8–10]; fibronectin, another ECM glycoprotein, medi-
ates microorganism uptake [11]; HA has been shown to be a
potent inhibitor of phagocytosis in vitro [12]. Macrophages
possess receptors for ECM proteins, which affect the biochemi-
cal and functional profile of macrophages [13], and are able to
release numerous proteases that degrade ECM macromolecules
[14].
Quantitative or structural changes in ECM are often reflected
in changes in the differentiation or functional state of cells
because they have been shown to correlate to in vitro differentia-
tion of monocytes into macrophages [15, 16]. Connective tissue
proteins and phagocyte cell functions are thus strictly related.
Furthermore, ECM is a complex and dynamic reservoir of
cytokines that regulate or modify cellular responses in inflam-
matory and immune reactions inducing biological responses by
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binding to specific cell surface receptors [17]. It has been
shown that the in vitro exposure of human monocytes and
monocyte-derived macrophages to microbial infections induces
the release of proinflammatory cytokines such as interleukin-1
(IL-1) and interleukin-6 (IL-6) [18].
In previous studies we showed that macrophages, treated
with HA or CS, underwent changes in shape and in the
organization of the cytoskeleton and modified their adhesion to
the substrate [19, 20]. The internalization of Candida albicans,
evaluated as cell-associated radioactivity, diminished after HA
or HS administration, whereas CS had no effects. Our results
therefore show a relationship between the macrophage pheno-
type and phagocytic functions and a role of GAG as modulators
of these functions.
To gain a better understanding of the relationship between
ECM components and macrophage functional heterogeneity, we
studied GAG profile of macrophages of different anatomical
origin, bone marrow-(ANA-1) and brain-derived (BV-2) macro-
phages. Both cell lines were exposed or not to C. albicans and
cultured in the presence of the two modulators of phagocytic
processes, IL-1a and IL-6.
MATERIALS AND METHODS
Cell cultures
The bone marrow-derived macrophage cell line ANA-1 and brain-derived BV2
macrophages were obtained from C57/BL6 mice by immortalization with a
recombinant retrovirus carrying the v-raf/v-myc oncogenes as previously
described [21, 22]. Cells were seeded in 1.75-mm-diameter Petri dishes at a
concentration of 106 cells/mL and cultured in RPMI 1640 medium supple-
mented with 10% heat-inactivated fetal calf serum (FCS), glutamine 2 mM,
antibiotics in a humidified atmosphere of 5% CO2 at 37°C.
Newly synthesized GAG isolation and
identification
For the biosynthetic labeling of GAG, ANA-1 and BV2 macrophage cells were
incubated for 6 and 48 h in RPMI 1640 medium 1 10% FCS and exposed to
[3H]glucosamine (25 µCi/mL; 28 Ci/mmol, Amersham) in the last 6 h of culture.
In a parallel set of experiments, macrophages were maintained for 30 h in
RPMI 1640 1 10% FCS with and without IL-1a or IL-6 (human recombinant,
Boehringer Mannheim) both at doses of 5 U/mL. Candida albicans, heat
inactivated for 30 min (iCa), ratio 1:5 compared to macrophages and
[3H]glucosamine (25 µCi/mL), was added in the last 6 h of culture. At the end of
the incubation times, cells and media were recovered separately. Cells were
scraped in 1 mL ice-cold 0.01 M Tris-HCl and 1.5 mM CaCl2 (pH 7.5) and lysed
by sonicating (amplitude 18) with six 10-s bursts using a B15P model Branson
sonicator. Media were dialyzed, lyophilized, and dissolved in the above buffer.
Lysates and media were boiled for 5 min and then digested for 3 days at 37°C
with 1 mg/mL predigested (for 30 min at 37°C) protease type XIV (Sigma
Chemical Co., St. Louis, MO) in the presence of 1% toluene. Fresh protease was
added daily. Proteins in the digested samples were precipitated with 10%
trichloroacetic acid (TCA), pelleted by centrifugation (12,000 rpm), and
discarded. GAG were precipitated from recovered supernatants with 3 volumes
of 5% potassium acetate in absolute ethanol in the presence of 100 µg of GAG
carrier and pelleted by centrifugation for 20 min at 12,000 rpm. GAG were
dissolved in 0.1 M Tris-HCl pH 7.2 and aliquots of [3H]GAG were mixed with 3
mL of Ultima Gold (Canberra Packard Int. S.A., Zurich, Switzerland) and
counted in a Packard Tri-Carb 2425 liquid scintillation counter.
Aliquots of media containing [3H]GAG were applied to a DE-52 cellulose
anion exchange column (0.5 3 6 cm), equilibrated with 10 mM Tris-HCl (pH
7.2) and eluted at room temperature with increasing stepwise concentrations of
NaCl (0.1, 0.3, 0.4, 0.5, 0.6 M). One-milliliter fractions were collected; 0.2-mL
aliquots were mixed with 3 mL of Ultima Gold and counted in a liquid
scintillation counter. Column fractions corresponding to specific types of GAG
were pooled, dialyzed, and lyophilized. Standard GAG (Sigma) were then added
and precipitated with 3 volumes of 5% potassium acetate in ethanol.
Radioactivity was measured in both supernatants (digested GAG) and pellet
(undigested GAG).
Individual GAG were identified by their susceptibility to specific enzymes.
Testicular hyaluronate lyase (beef, Miles Italiana, S.P.A., Cavenago Brianza,
Milano, Italy) and streptomyces hyaluronate lyase (Streptomyces hyaluroniticus,
Seikagaku Kogyo Co.) digestions were performed by dissolving lyophilized
samples in 0.02 M sodium acetate buffer, pH 5, containing 0.1 M NaCl, at 37°C
for 24 h with 30 and 5 enzyme units, respectively. Chondroitin AC-II lyase
(Arthrobacter aurescens, Seikagaku Kogyo Co.) digestions were performed in
0.01 M Tris buffer, pH 8, at 25°C for 24 h with 0.5 and 0.01 enzyme units.
Nitrous acid was used to degrade heparan sulfate. Recovery of the fractionating
procedure was about 85–95%. Results are expressed as cpm/mg of protein [23].
Statistical analysis
Statistical analysis was performed by Students’ t test. Results reported in tables
and figures are the mean 6 SEM for quadruplicate cultures from a typical
experiment. Similar results were obtained in three independent experiments.
RESULTS
Incorporation of [3H]glucosamine into GAG in
ANA-1 and BV-2 macrophages as a function
of time
ANA-1 and BV-2 macrophages were incubated for various
times in complete medium containing [3H]glucosamine to
analyze the kinetics of cellular and secreted GAG (Fig. 1). It is
noteworthy that neosynthesized GAG were retained more in the
cellular compartment. The radioactivity assayed in the medium
was about half of that present in the cell pellet. The radioactiv-
ity of both cellular and extracellular GAG increased approxi-
mately linearly across the incubation times. After 6 h of culture
the amount of cellular GAG from BV-2 cell line was higher
compared to the ANA-1 line (Fig. 1A). On the other hand, after
48 h of culture the amount of endocellular GAG in the ANA-1
cells was significantly higher than that in the BV-2 cells. As far
as the GAG secreted in the medium is concerned (Fig. 1B), the
results demonstrate that after 36/48 h, the macrophages of the
ANA-1 line secreted significantly more GAG compared to the
macrophages of the BV-2 line. Therefore on the whole the
macrophages of the ANA-1 line in culture produce a greater
quantity of total GAG compared to that produced by the BV-2
line (Fig. 1C).
Composition of labeled secreted GAG
Ionic exchange chromatography demonstrated the presence of
five classes of secreted GAG, namely hyaluronic acid (HA),
chondroitin (Ch), heparan sulfate (HS), chondroitin sulfate
(CS), and dermatan sulfate (DS; Fig. 2). In both macrophage
populations, after 6 h HA was the dominant GAG and HS and
CS represented about 50% of the HA. After 48 h of mainte-
nance in vitro, the ANA-1 macrophages produce a lower
quantity of HA compared to that produced by the BV-2
macrophages. In both cell lines it was seen that increasing the
in vitro maintenance time from 6 to 48 h, the HA/sulfated GAG
ratio shifted in favor of the latter.
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GAG synthesis and profile in IL-1- or IL-6-treated
ANA-1 and BV-2 macrophages during
iCa exposition
Both IL-1 and IL-6 treatment of ANA-1 macrophages reduced
cellular and extracellular GAG; the inhibition effect on se-
creted GAG was seen to a greater extent with IL-6 (decrease of
78% for IL-6, decrease of 61% for IL-1; Table 1). ANA-1
macrophages exposed to iCa had a lower GAG content com-
pared to the controls both in the cellular (decrease of 25%) and
extracellular compartment (decrease of 36%). Therefore, the
inhibitory effect induced by iCa on the intra- and extracellular
GAG quota was less than that induced by the two cytokines.
Fig. 1. Kinetics of GAG synthesis in bone marrow- and brain-derived macrophage cell lines (ANA-1, filled circles; BV-2, open circles). The periods of incubation
time are indicated. [3H]glucosamine (25 µCi/mL) was added in the last 6 h of culture. Values are expressed as cpm/mg protein and represent the mean for four
determinations from a typical experiment. For all determinations, standard deviation was less than 15%. Similar results were seen in three independent experiments.
652 Journal of Leukocyte Biology Volume 64, November 1998
Treatment of BV-2 macrophages with IL-1 also induces a
reduction in GAG, but the effect is limited to the intracellular
compartment (decrease of 35%, data not shown). Exposure of
BV-2 to iCa alone or in combination with IL-1 does not show
any modifications in the total GAG. In the presence or absence
of iCa, IL-6 induces a significant reduction both of the GAG
accumulated in the cells and the secreted GAG (decrease of 27
and 21%, respectively, data not shown).
Analysis of individual secreted GAG classes secreted by
ANA-1 macrophages (Fig. 3 and Table 2) showed that IL-1
addition induced an increase of the percentage of HA (more than
double) and a decrease of HS and CS with an increase of the
HA/sulfated GAG. In iCa-treated macrophages, the HA percentage
was moderately enhanced compared to the controls; the radioactivity
incorporated into HS and CS was significantly reduced, whereas the
percentage of DS was about fourfold above the controls. After
combined treatment with iCa and IL-1, the percentage of HA
increased, as also seen following treatment with iCa alone. A further
decrease in HS and a more significant increase in DS percentage
were seen. IL-6 treatment induced a slight increase in the
percentage of HA and HS, a considerable increase in DS, and a
sharp decrease in CS. The HA/sulfated GAG ratio was in favor
of sulfated GAG. Combined treatment with IL-6 and iCa
produced an increase in the HS percentage.
In BV-2, treatment with IL-1 or IL-6 induced fewer modifications
in redistribution of the percentage of individual GAG classes (Table
2). In fact both the ILs determine only a slight decline in the HA and
a modest increase in the CS. The most significant event during
exposure to iCa is the increase in the HS percentage.
DISCUSSION
Relatively little is known concerning the relationship among
ECM components and cells of the immune system. Neverthe-
TABLE 1. Effects of IL-1 or IL-6 on [3H]glucosamine Incorporation











Control 23,736 6 1,945 13,895 6 975 37,631 1.37 6 0.01
IL-1 18,207 6 3,456b 5,370 6 517a 21,664 1.32 6 0.04d
iCA 17,675 6 460a 8,951 6 1,178a 26,626 1.35 6 0.02d
IL-1
1 iCa 16,363 6 1,308a 6,225 6 330a 22,588 1.45 6 0.01d
IL-6 20,690 6 1,892c 3,018 6 70a 23,708 1.36 6 0.03d
IL-6
1 iCa 17,137 6 1,872a 7,342 6 841a 24,479 1.36 6 0.01d
ANA-1 macrophages were maintained in RPMI 1640 1 10% FCS for 30 h
with or without IL-1a or IL-6 (both at the dose of 5 U/mL). [3H]glucosamine (25
µCi/mL) and iCa (heat inactivated for 30 min, ratio 1:5) were added in the last 6
h and processed as described in Materials and Methods. [3H]glucosamine
incorporation was evaluated into cellular and extracellular GAG. Values are
expressed as cpm/mg protein and represent the mean 6 SD for four
determinations from a typical experiment. Similar results were seen in three
independent experiments. Differences versus each control are significant for
a P , 0.001, b P , 0.01, c P , 0.05, d not significant.
Fig. 2. Anion exhange elution profile of GAG synthesized by ANA-1 and BV-2 macrophage cell lines maintained in RPMI 1640 1 10% FCS for 6 and 48 h.
[3H]glucosamine (25 µCi/mL) was added in the last 6 h of culture. Values are representative of a single chromatography. Similar results were obtained in three
independent experiments. *Percent secretion in the medium.
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less, it is well-known that the interactions between monocytes
and ECM proteins represent an important stimulus for differen-
tiation of macrophages [24–26]. ECM macromolecules, gener-
ated at inflammatory sites, affect macrophage adherence,
phagocytosis, and local cytokine production. Various hypoth-
eses have been put forward regarding the mechanisms by which
the ECM components influence phagocytosis. These hypoth-
eses include the following: a direct effect on the number of
ECM surface receptors, a change in the receptor typology, an
effective link between receptors and cytoskeletal components
affecting in turn the endocytosis vesicles. [19, 20, 27, 28].
This study was conducted in two macrophage cell lines
obtained from different anatomical areas with different func-
tional and secretory activities [29–31]. Previous studies showed
that the two cell lines actively phagocytize Candida, although
macrophages of microglial origin were the most effective [31,
32]. We have now shown that in ANA-1 and BV-2 macrophages,
the biosynthetic program for GAG is different, since each cell
line exhibited a peculiar GAG pattern, modulated by IL-1a and
IL-6 treatment and further altered after exposition to a phago-
cytic stimulus. In ANA-1, more than in BV-2, total GAG
synthesis is greatly inhibited by treatment with IL-1a and IL-6.
In both macrophage populations, iCa exposure tends partially
or completely to remove the strong inhibitory effect induced by
ILs.
Chromatographic analysis of the media showed that ILs have
a greater modulating effect on the ANA-1 line than on BV-2. In
ANA-1, in fact, IL-1a treatment decreases the quota of sulfated
GAG, in particular shifting the HA/sulfated GAG ratio in favor
of HA. This ratio is modified during iCa exposure or after
treatment with IL-6 and/or iCa. BV-2 reveals a different
phenotype compared to ANA-1 with increased production of
HA. Exposure to iCa lowers the HA/GAG sulfated ratio
Fig. 3. Anion exchange profile of GAG synthesized by ANA-1 macrophages maintained in RPMI 1640 1 10% FCS for 30 h with or without IL-1a or IL-6 (both 5
U/mL) in presence or absence of Candida (iCa, heat inactivated for 30 min, ratio 1:5). Values are representative of a single chromatography. Similar results were
obtained in three independent experiments.
TABLE 2. Percentage of [3H]Glucosamine Incorporation into
Individual GAG Classes Secreted by ANA-1 and BV-2 Macrophage
Cell Lines
HA Ch HS CS DS
ANA-1
Control 20 1.5 32.8 43.2 2.5
IL-1 50 1.5 21.5 20 7
iCa 27 2 29 31 11
IL-1 1 iCa 48 1 10.2 19.8 21
IL-6 28 1.5 37 6.5 27
IL-6 1 iCa 23.3 1 59 7.2 9.5
BV-2
Control 66 2 25 5 2
IL-1 61.3 3.5 25 8 2.2
iCa 57.2 3 32 6 1.8
IL-1 1 iCa 59 2 25 12 2.1
IL-6 64.5 1.5 26 6 2
IL-6 1 iCa 62 1 30 5 2
ANA-1 and BV-2 macrophage cell lines were maintained in RPMI 1640 1
10% FCS for 30 h with or without IL-1a (5 U/mL) or IL-6 (5 U/mL). Candida
albicans (heat inactivated for 30 min, ratio 1:5) and [3H]glucosamine were
added in the last 6 h of culture. Aliquots of media were applied to DE-52
cellulose anion exchange column and processed according to Materials and
Methods. Values are representative of a single chromatography. Similar results
were obtained in three independent experiments.
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inducing a relative increase in HS, whereas the ILs induce a
modest modification in the expression of individual GAG
classes. On the whole the results prove that since ANA-1 and
BV-2 come from different anatomical sites, they each have
particular GAG patterns and respond differently to treatment
with the cytokines. These data may have functional implica-
tions. In fact macrophages bind HA and possess HA receptors,
as well as being able to degrade HA [33–35]. HA, in its turn,
reduces IL-1-stimulated proteoglycan degradation [36]. The
altered balance between HA amount and sulfated GAG during
iCa and IL treatment may be important during the process of
migration of macrophages through the ECM and represents a
critical aspect of phagocytic functions [37].
Cytokines show selective and differential binding to gly-
cosaminoglycans or core protein of proteoglycans [38]. IL-1b
partially binds to hyaluronic acid, whereas IL-1a shows
essentially no retention. Selective, partial binding to acidic
polysaccharides is also exhibited by IL-6, which binds heparin,
dextran sulfate, and dermatan sulfate but is poorly retained on
chondroitin sulfate [39, 40].
Furthermore, a cascade control of cytokine production has
been indicated [41–43], as well as the role of cytokines in host
defense [44–46]. Cytokines secreted by macrophages greatly
influence, in an autocrine manner, the ability of macrophages to
defend against microbial challenge [47]. The up-regulation of
IL-1a and the down-regulation of IL-6 due to changes in IL-1
and/or HA amounts might broadly affect aspects of the delicate
balance of the cytokine network during immunity response.
Furthermore we, like others [48–52], have shown that
macrophage-derived growth factors are able to modulate the
function of normal and pathological fibroblasts affecting colla-
gen and GAG synthesis and driving the fibro-proliferative
responses. Therefore, ECM components become the modulatory
signals of a microenvironment, where they modulate the genetic
program and control the cytokine release responsible for the
fibrotic processes of many connective disorders.
In conclusion, our results provide the first evidence that
GAG profile of macrophages is modulated by incubation with
IL-1, IL-6, or iCa, suggesting a close relationship between
GAG-sulfated and non-sulfated composition and release, IL
production, and macrophage functions. Further studies are
necessary to verify the mechanism through which the composi-
tion in the individual GAG classes constitutes an important
means of metabolic control of the different macrophage functions.
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